P005 Innovation in Business and Leadership in Dermatology
DESCRIPTION
Medicine is one of the largest Businesses in the world. Most medical training does not involve learning about this important topic. In this session Dermatologists and trainees will learn about innovation in various aspects of Business and Leadership in Medicine and Dermatology.
LEARNING OBJECTIVES
Describe various innovations in business of Dermatology and Medicine
Outline various practice settings for Dermatologists and Trainees and how to improve it with innovative approaches
Describe innovation in leadership: “Perspectives from AAD and AMA”
SCHEDULE
10:00 AM
Innovation in running and starting a successful Dermatology Practice
Mark D. Kaufmann, MD, FAAD
10:15 AM
Innovation in running a successful Surgical Dermatology Practice
Howard Wooding Rogers, MD, PhD, FAAD
10:30 AM
Innovation in running a successful Dermatopathology practice
Tammie C. Ferringer, MD, FAAD
10:45 AM
Innovative ways to get involved with AAD Leadership
Daniel D Bennett, MD, FAAD
11:00 AM
Innovation in Teledermatology
George Han, MD, PhD, FAAD
11:15 AM
AI in dermatology
Faranak Kamangar, MD, FAAD
11:30 AM
Innovation in running a successful Pediatric Dermatology practice
Robert Sidbury, MPH, MD, FAAD
11:45 AM
Panel discussion and Q & A
DIRECTOR
Keyvan Nouri, MBA, MD, FAAD
SPEAKERS
Daniel D Bennett, MD, FAAD
Tammie C. Ferringer, MD, FAAD
Geisinger Med Center
George Han, MD, PhD, FAAD
Faranak Kamangar, MD, FAAD
Mark D. Kaufmann, MD, FAAD
Howard Wooding Rogers, MD, PhD, FAAD
Robert Sidbury, MPH, MD, FAAD
DISCLOSURES
Daniel D Bennett, MD, FAAD
No financial relationships exist with ineligible companies.
Tammie C. Ferringer, MD, FAAD
No financial relationships exist with ineligible companies.
George Han, MD, PhD, FAAD
Aclaris Therapeutics, Inc. – Advisory Board(Honoraria); Alumis – Investigator(Grants/Research Funding); Avillion – Investigator(Grants/Research Funding); Boehringer Ingelheim – Advisory Board(Honoraria), Investigator(Grants/Research Funding); Bristol-Myers Squibb – Advisory Board(Honoraria); Eli Lilly and Company – Advisory Board(Honoraria), Investigator(Grants/Research Funding); First Tracks Biotherapeutics – Advisory Board(Honoraria); Incyte – Investigator(Grants/Research Funding); Incyte Corporation – Advisory Board(Honoraria); Janssen Pharmaceuticals, Inc – Advisory Board(Honoraria), Investigator(Grants/Research Funding), Speaker(Honoraria); LearnHealth/LearnSkin – Speaker/Faculty Education(Honoraria); Leo Pharma – Advisory Board(Honoraria); Novartis Pharmaceuticals Corp. – Investigator(Grants/Research Funding); Ortho Dermatologics – Advisory Board(Honoraria); Pfizer Inc. – Speaker(Honoraria); Regeneron Pharmaceuticals, Inc. – Advisory Board(Honoraria), Investigator(Grants/Research Funding), Speaker(Honoraria); Sanofi – Advisory Board(Honoraria); Sanofi Genzyme – Speaker(Honoraria); Sun Pharmaceutical Industries Ltd. – Speaker(Honoraria); Takeda Pharmaceuticals USA Inc – Advisory Board(Honoraria); UCB – Advisory Board(Honoraria), Speaker(Honoraria);
Faranak Kamangar, MD, FAAD
No financial relationships exist with ineligible companies.
Mark D. Kaufmann, MD, FAAD
Almirall – Consultant (1099 relationship)(Fees); Apogee Therapeutics – Consultant (1099 relationship)(Fees); Biofrontera – Consultant (1099 relationship)(Fees); Botanix Pharmaceuticals – Advisory Board(Fees); CryoCaptures LLC – Stockholder Private Company(Stock); Dermsquared – Stockholder Private Company(Stock); DermTech Inc. – Consultant (1099 relationship)(Fees); Feldan Therapeutics – Consultant (1099 relationship)(Fees); Genius Clinic, Inc – Stockholder Private Company(Stock Options); Incyte – Consultant (1099 relationship)(Fees); Novartis – Consultant (1099 relationship)(Fees); NuVida – Advisory Board(Fees); Oruka Therapeutics – Consultant (1099 relationship)(Fees); Peerwise Medical Corp – Stockholder Private Company(Stock); Pelthos Therapeutics – Consultant (1099 relationship)(Fees); Sanofi/Regeneron – Consultant (1099 relationship)(Fees); SciBASE – Consultant (1099 relationship)(Fees); Sun Pharmaceutical Industries Ltd. – Consultant (1099 relationship)(Fees); UCB Pharma – Consultant (1099 relationship)(Fees); VeraDermics Inc. – Advisory Board(Fees); Verrica Pharmaceuticals Inc – Consultant (1099 relationship)(Fees); Xtresse – Stockholder Private Company(Stock);
Keyvan Nouri, MBA, MD, FAAD
iVeena Delivery Systems-Eye Drug Delivery – Stockholder(No Compensation Received); Pfizer Inc. – Stockholder(No Compensation Received);
Howard Wooding Rogers, MD, PhD, FAAD
Biofrontera AG – Consultant (1099 relationship)(Fees);
Robert Sidbury, MPH, MD, FAAD
Alphyn Biologics – Consultant (1099 relationship)(Fees); Arcutis, Inc. – Advisory Board(Honoraria); Dermavent – Advisory Board(Honoraria); Eli Lilly – Advisory Board(Honoraria); Galderma Global – Consultant(Honoraria); Leo Pharma Inc – Advisory Board(Honoraria); Regeneron Pharmaceuticals, Inc. – Investigator(No Compensation Received);